Impact of Inâ  Hospital Death on Spending for Bereaved Spouses by Ornstein, Katherine A. et al.
Impact of In-Hospital Death on
Spending for Bereaved Spouses
Katherine A. Ornstein , Melissa M. Garrido , Albert L. Siu,
Evan Bollens-Lund, Kenneth M. Langa, and Amy S. Kelley
Objective. To examine how patients’ location of death relates to health care utiliza-
tion and spending for surviving spouses.
Data Sources/Study Setting. Health and Retirement Study (HRS) 2000–2012
linked to the Dartmouth Atlas andMedicare claims data.
Study Design. This was an observational study.Wematched bereaved spouses whose
spouses died in a hospital to those whose spouses died outside the hospital using
propensity scores based on decedent and spouse demographic and clinical characteris-
tics, care preferences, and regional practice patterns.
Data Collection/Extraction Methods. We identified 1,348 HRS decedents with
surviving spouses. We linked HRS data from each dyad with Medicare claims and
regional characteristics.
Principal Findings. In multivariable models, bereaved spouses of decedents who
died in the hospital had $3,106 higher Medicare spending 12 months postdeath
(p = .04) compared to those whose spouses died outside a hospital. Those surviving
spouses were also significantly more likely to have an ED visit (OR = 1.5; p < .01) and
hospital admission (OR = 1.4; p = .02) in the year after their spouse’s in-hospital death.
Increased Medicare spending for surviving spouses persisted through the 24-month
period postdeath ($5,310; p = .02).
Conclusions. Bereaved spouses of decedents who died in the hospital had signifi-
cantly greater Medicare spending and health care utilization themselves after their
spouses’ death.
Key Words. End of life, caregiving, bereavement, treatment intensity, palliative
care, Medicare
Caregivers play a vital role in the care of older adults with disabilities and seri-
ous illness across all disease stages including the end-of-life (EOL) period
(Institute of Medicine 2014; National Academies of Sciences 2016; Ornstein
et al. 2017b). Yet family caregivers are also at increased risk of poor health.
Decades of research suggests that while there may be benefits to providing





care (Cohen, Colantonio, and Vernich 2002; Roff et al. 2004; Tarlow et al.
2004), caregivers are also vulnerable to increased depression (Pinquart and
Sorensen 2003) and other health problems (Ho et al. 2009; Buyck et al. 2013),
and reduced preventive health behaviors (Son et al. 2007; Reeves, Bacon, and
Fredman 2012). As a consequence, caregiving is often associated with
increased health care costs (Van Houtven, Wilson, and Clipp 2005; Schulz
and Cook 2011) and may even lead to increased mortality (Schulz and Beach
1999).
The experience of caring for loved ones at the EOL in particular may
impact the health and well-being of the caregiver. Intensive Care Unit (ICU)
admissions, for example, are associated with post-traumatic stress for care-
givers (Anderson et al. 2008; Davidson, Jones, and Bienvenu 2012; Schmidt
and Azoulay 2012). Families report worse physical and mental health follow-
ing deaths when intensive, life-sustaining treatments were performed at EOL
(Wright et al. 2008; Ornstein et al. 2017a). On the other hand, low-intensity,
comfort-focused treatments such as hospice may mitigate the negative impact
of caregiving on families. Beneficial effects of hospice use on caregivers
include better bereavement adjustment (Godkin, Krant, and Doster 1983;
Seale 1991), increased satisfaction (Kane et al. 1985; Seale 1991; Teno et al.
2005), and decreased depression (Bradley et al. 2004; Wright et al. 2008,
2010; Ornstein et al. 2015a). Similarly, improved outcomes for family mem-
bers, including adjustment to death postbereavement (Abernethy et al. 2008)
and better reported quality of death (Garrido and Prigerson 2014), are associ-
ated with use of palliative care services.
Whether the impact of the patient’s EOL treatment experience extends
to family members’ own health care utilization is largely unknown. Most care-
givers increase their own utilization once caregiving ends and they can better
attend to their own health needs (Prigerson, Maciejewski, and Rosenheck
2000; Stroebe, Schut, and Stroebe 2007; Guldin et al. 2013). But to date, there
is a lack of research on what factors impact utilization of health care by
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surviving caregivers (Stajduhar et al. 2010). This is a remarkable gap in knowl-
edge given that (1) our social networks play a significant role in our own health
behaviors and events (Smith and Christakis 2008) and (2) the negative health
effects associated with caregiving are associated with reduced preventive
health behaviors (Reeves, Bacon, and Fredman 2012), which may ultimately
increase health care utilization. Understanding how the health care experience
impacts family members is critical to the development of effective interven-
tions to mitigate negative effects of caregiving. Moreover, advancing current
policy initiatives designed to simultaneously improve health outcomes and
the cost effectiveness of the health care system requires a better understanding
of what the downstream effects of health care and treatment intensity are on
the family.
Conceptual Framework
Our conceptual framework for understanding the impact of the patient’s EOL
care experience on family members’ own health care (Ornstein et al. 2015b) is
based on an adapted version of the Aday-Anderson behavioral model of
health care utilization (Aday and Andersen 1974) and incorporates the stress
process model of caregiving (Pearlin et al. 1990), the role of patients’ suffering
on families (Schulz et al. 2007, 2009), and shared social networks (Christakis
2004). We posit that family health care utilization may be related to patient
treatment intensity because of shared values and preferences about health
care, financial burdens related directly or indirectly to the patient’s care, and
the personal experience of witnessing the patient’s symptoms, suffering, and
challenging incidents within the health care system.
The Aday-Anderson model proposes that predisposing, enabling, and
need characteristics influence access to and use of health care. Predisposing
factors are the “immutable” characteristics of the family member (e.g., demo-
graphics) as well as their caregiving role both at the end of life and in the long
term. Enabling factors include resources individuals have available to them
(e.g., insurance, regional service availability). Need factors refer to the condi-
tions that necessitate health care utilization. The stress process model concep-
tualizes caregiving as a chronic stressor that gives rise to strains in multiple
domains and ultimately leads to increased risk for psychiatric distress and
physical illness burden. Furthermore, exposure to patient suffering (opera-
tionalized as physical, psychological, and existential/spiritual) is an indepen-
dent source of distress for caregivers. We posit that the intensity of health care
treatment received by a patient influences patient symptoms, suffering, and
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costs, which in turn impact enabling factors for the family caregiver such as
financial and time burden and lack of belief in the efficacy of the health care
system. Because of this burden, there is a decrease in preventive and self-care
behaviors, which ultimately results in increased urgent care use and health
care spending for bereaved family members. Finally, family health care uti-
lization is impacted by patient health care utilization within the context of
shared social networks (Christakis 2004). Individuals are linked based on their
social relationship within a social network, which are known to impact health
behaviors such as smoking, weight gain, and cancer screening (Christakis and
Fowler 2007). Behaviors such as use of high-intensity treatments at EOL may
be impacted by shared experiences within these social networks.
Guided by our model, the goal of this study was to test whether the EOL
care experience of a person impacts the downstream health care utilization for
surviving spouses. We conceptualize treatment intensity at the end of life as a
high degree of medical intervention, most often taking place in a hospital set-
ting. Although hospitalizations are the most common marker of treatment
intensity, there is no uniform marker or timeframe (Luta et al. 2015). We
focused on in-hospital death as a broad and commonly used marker of high-
intensity EOL treatment relevant to all decedents, not just those with a specific
illness or in a specific setting (i.e., not just limited to those with cancer or hospi-
talized), as compared to death in a nonhospital location.
METHODS
Study Population
The Health and Retirement Study (HRS), a nationally representative, longitu-
dinal survey of U.S. adults 51 years of age and older (Health and Retirement
Study 2013), interviews participants every two years. If participants are mar-
ried or partnered, their partners (heretofore referred to as “spouses”) are
recruited into the study and surveyed. During each interview cycle, HRS iden-
tifies participants who have died since the last interview wave. In these cases, a
postdeath interview is conducted with someone who is knowledgeable about
the deceased participant. HRS survey data are linked for eligible participants
with individual Medicare claims. Study participants provided informed con-
sent upon enrollment and again for linkage to Medicare claims. We identified
3,226 respondents who died between 2000 and 2011 and were survived by a
spouse. Because our main outcome was spouse postdeath utilization, we lim-
ited our sample to 1,548 decedents whose spouses had completed an HRS
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interview, were over age 65, and had fee-for-service (FFS) Medicare at the
time of the decedent’s death. Finally, we excluded 173 dyads due to missing
data required for propensity score matching.
Measures
Outcome Measures. The primary outcome was the surviving spouse’s total Medi-
care expenditures during the 12 months after his or her spouse’s death. This
measure includes all Medicare payments for inpatient, outpatient, skilled nurs-
ing facility, hospice and home care, and durable medical equipment. Claims
spanning the 365th day after death were prorated to include only the expendi-
tures within the one-year period. We adjusted expenditures for inflation (2012$)
based on the consumer price index, and for geographic differences in Medicare
price levels using the Centers for Medicare and Medicaid Services (CMS) wage
index. We also used Medicare claims to determine whether surviving spouses
had any inpatient admissions or emergency department (ED) visits.
Independent Variables. Based on previous work (Kelley et al. 2011), we used
HRS postdeath interview data to create a binary indicator of in-hospital death
versus death in any other location. Being in the hospital at the time of death is
indicative of a higher level of treatment intensity in the time immediately pre-
ceding death and is therefore distinct from death in other settings (home,
assisted living, nursing home, hospice facility, and other), which were consid-
ered “nonhospital death.”
Other Measures. Based on our group’s conceptual frameworks for understand-
ing multilevel predictors of treatment intensity (Kelley et al. 2010) and the
impact of patient treatment intensity on family members’ own health care
(Ornstein et al. 2015b), we identified factors that could be associated with both
likelihood of in-hospital death and spousal postdeath health care spending. To
account for this potential confounding, we used propensity score matching (as
described below) based upon the following spousal, decedent, and regional
level variables.
Spousal factors drawn from the spouse’s last HRS core interview before
the patient’s death included age, sex, race/ethnicity, education, net worth, self-
reported health, functional status, and level of comorbidity. We also identified
whether the spouse was the primary helper with the decedent’s activities of
daily living (ADLs) or instrumental activities of daily living (IADLs) at the
EOL from the postdeath interview.
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Decedent factors were extracted from decedents’ final HRS core inter-
view. HRS core interview data included the following: insurance coverage,
functional status (whether the participant had difficulty with one or more basic
ADLs), residential status (nursing home or community-dwelling), and self-
reported health. Probable dementia was determined via clinically validated
algorithm (Hurd et al. 2013). Self-report illness data were used to determine
cancer diagnosis and level of comorbidity. If the core interviewwas completed
within the month before death, data were drawn from the previous interview.
Presence of advance directives and whether or not the family expected the
death were extracted from the postdeath interview.
Using the decedent’s zip code, each dyad was linked via their hospital
referral region (HRR) to the Dartmouth Atlas of Healthcare’s End of Life
Expenditure Index (EOL-EI), a measure of physician practice patterns, based
uponMedicare beneficiaries’ utilization in the last 6 months of life (Wennberg
and Cooper 2013). We created an indicator for those living in the top quartile
of EOL-EI by HRR.
Analysis. Propensity scores were calculated using logistic regression of in-hos-
pital death. Prior to matching, we checked the balance of covariates across the
groups who did and did not die in-hospital within strata of the propensity
score. We then used caliper matching with replacement to match those who
died in-hospital to one or many decedents who died outside of the hospital
within 0.02 of the standard deviation of the logit of the propensity score (Stu-
art 2010). Balance was then verified by examining standardized differences in
covariates across treatment groups and variance of covariates before and after
matching. Standardized differences < 10 percent indicated adequate balance
(Austin 2009; Garrido et al. 2014).
Using the propensity-score matched sample, we first estimated differ-
ences in 12-month Medicare expenditures and hospitalization and ED visits
based on nonparametric equality of medians test and chi-square test of propor-
tions. In our primary analysis, we estimated a multivariable generalized linear
(GLM) model of 12-month Medicare expenditures postdeath. Due to the
skewed distribution of the outcome, we used a gamma distribution with a log
link. Regression coefficients were exponentiated into rate ratio estimates, and
average marginal effects were calculated to produce average treatment effects
on the treated. For our secondary outcomes, incidence of hospitalization, and
ED admission 12 months postdeath, we estimated multivariable logistic
regression models. In all models, we controlled for all covariates included in
the propensity score to adjust for any remaining imbalance between the
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groups after matching (Stuart 2010). We also included an indicator for year of
death to account for secular trends.
We conducted a series of sensitivity analyses. First, we repeated the anal-
yses described above using 24 months postdeath spending as the outcome.
We also repeated analyses limiting our sample to those spouses who survived
at least 12 months beyond the death of their spouse. To account for individual
variation in baseline spending, we limited our sample to those spouses with
continuous FFS Medicare 18 months before death. We used the one-year per-
iod from 6 to 18 months before death to determine “baseline spending” levels
to avoid any deviation from typical health care utilization patterns due to the
spouse’s illness and approaching death. We repeated our analyses with only
those spouses in highest baseline spending quartile. Finally, we included quar-
tile of predeath spending in our match and reran primary and secondary out-
comes. For each additional analysis, we re-estimated the propensity score and
created newmatched subsamples with balanced observed covariates.
RESULTS
Surviving spouses were mean age 77.8 years, and 72.6 percent had at least a
high school education (Table 1). The majority of surviving spouses (89.0 per-
cent) were independent in all ADLs prior to their spouse’s death
(mean = 12.7 months). Decedents had a mean age of 80.5 years at death;
69.2 percent were men, 85.8 percent were non-Hispanic white, and 68.1 per-
cent had at least a high school education. More than one-third (38.9 percent)
of decedents died in the hospital. The remainder died at home (including
assisted living facilities) (32.0 percent), in a nursing home (18.4 percent), or in
hospice facilities (8.7 percent).
Prior to matching, there were significant differences among dyads where
the decedent died in the hospital compared to those who died elsewhere. Sur-
viving spouses of those who died in the hospital were less likely to be non-His-
panic white (80.1 percent vs. 88.3 percent) and less likely to have a high school
degree (69.5 percent vs. 74.5 percent). The decedents who died in the hospital
were less likely to have dementia (23.1 percent vs. 31.4 percent), cancer (22.2
percent vs. 33.5 percent), be ADL dependent (31.1 percent vs. 42.1 percent),
live in nursing homes (4.2 percent vs. 12.0 percent), have advance directives
(55.5 percent vs. 62.8 percent), or have an expected death (48.1 percent vs.
67.0 percent). Those who died in the hospital were more likely to live in high-
spending EOL-EI HRRs (32.3 percent vs. 23.5 percent) (Table 1).
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In our matched sample (99.2 percent of complete sample), observed
confounders were balanced (<10 percent standardized difference) (Table 1)
(Austin 2009). Spouses of those who had an in-hospital death had consistently
higher spending up to 24 months after death (see Figure 1). In bivariate analy-
ses, spouses of those who died in the hospital had $4,000 higher Medicare
expenditures during the 12 months after death (p < .01) and were more likely
to be hospitalized (28.7 percent vs. 22.5 percent; p = .02) and visit the ED in
the year after their spouse died than those whose spouses died outside of the
hospital (39.2 percent vs. 30.8 percent; p < .01). These significantly higher
levels of expenditures and utilization persisted for the 24-month period after
death of a spouse (Table 2).
In multivariable analysis, in-hospital death was independently associ-













21-24m 9-12 0-3 0-3 9-12 21-24m
Months from index date
In-hospital death Nonhospital death
Figure 1: Mean Medicare Expenditures and 95 Percent CI of Bereaved
Spouses before and after Death by Location of Death [Color figure can be
viewed at wileyonlinelibrary.com]
Notes:Medicare expenditures are wage index and inflation adjusted to 2012$; figure includes mean
quarterly expenditures among those spouses with fee-for-service Medicare at the time of their
spouse’s death (n = 1,348; 2418.1 person-years of follow-up after death and 2399.8 person-years of
follow-up after death) adjusted based on propensity for in-hospital death; CI, confidence Intervals.
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first year (p = .04) and a $5,310 mean increase in spending over 2 years
(p = .02) (Table 3). Spouses of those who died in the hospital had a 43 percent
increased odds of being hospitalized in the 12 months following the death of
their spouse (p = .02). Similarly, spouses of those who died in the hospital had
a 51 percent increased odds of visiting the ED in the 12 months following the
death of their spouse (p ≤ .01). These differences in spending remained up to
24 months after the death of their spouse (see Table 3).
In 90 percent of dyads, the surviving spouse lived at least 12 months
after the death of their spouse. When limiting our analyses to these dyads, our
findings remained unchanged (see Table S1). In-hospital death was associated
with 26 percent increased meanMedicare expenditures (p = .04).
Spouses’ annual median baseline health care spending ranged from
$330 (lowest quartile) to $21,082 (highest quartile) (see Table S2). In matched
fully adjusted analyses limited to the highest quartile of baseline spenders,
there was a $15,223 marginal difference in spending after death among
spouses of those who died in the hospital (p < .01) compared to those who
experienced a nonhospital death. This group also had a statistically significant
twofold increase in hospital and ED utilization 12 months after the death of
their spouse. Significantly higher expenditures and likelihood of utilization
Table 2: Medicare Expenditures and Utilization for Bereaved Spouses Post-
death by Location of Death (Matched Sample)












In-hospital death 526 15,959.7 3,387.1 28.7 39.2
Nonhospital death 822 11,775.5 3,099.6 22.5 30.8
p-value <.01 .02 <.01
24 months
In-hospital death 485 29,500.3 9,725.3 42.9 58.4
Nonhospital death 753 22,307.3 8,382.3 35.7 48.1
p-value <.01 .02 <.01
Note. Medicare expenditures are wage index and inflation adjusted to 2012$. Sample propensity
score matched based on: spouse age at death, gender, networth, race, education, self-reported
heath, comorbidity level, caregiving status; decedent age, self-reported health, ADL dependence,
dementia status, cancer diagnosis, level of comorbidity, residence, insurance status; presence of
advance directive; family expectation of death; and EOL spending by hospital referral region. p-
Values based on chi square test of proportions, nonparametric test of medians. Nonhospital death
includes the following locations: home, assisted living, nursing home, hospice facility, and other.
ED, Emergency Department.
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were evident 24 months postdeath (Table 4). We were unable to achieve ade-
quate balance across all matching variables for the lower three quartiles when
we stratified our analysis by quartile of spousal predeath spending.
In matched analyses that include quartiles of predeath spending in the
propensity score model (Table S3), in-hospital death remained significantly
associated with both 12-month hospitalization and ED utilization, although
forMedicare spending the effect size was reduced and lost significance.
DISCUSSION
Using a nationally representative sample of older decedents, we found that
bereaved spouses of those who died in the hospital had higher levels of
Table 3: Association between In-Hospital Death and Medicare Expendi-
tures and Utilization for Bereaved Spouses Postdeath
Postdeath Follow-Up Period
12 months 24 months
N 1,348 1,238
Medicare expenditures

















Note. Medicare expenditures are wage index and inflation adjusted to 2012$. Sample propensity
score matched based on spouse age at death, gender, networth, race, education, self-reported
heath, comorbidity level, caregiving status; decedent age, self-reported health, ADL dependence,
dementia status, cancer diagnosis, level of comorbidity, residence, insurance status; presence of
advance directive; family expectation of death; and EOL spending by hospital referral region and
adjusted for year of death. p-Values based onGLM and logistic regressionmodels.
ED, Emergency Department; IQR, interquartile range.
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Medicare spending and utilization themselves after the death, compared to
those whose spouses died outside of a hospital. Specifically, we found that
bereaved spouses of decedents who died in the hospital had more than $3,000
increased spending in the 12 months after death and over $5,000 increased
spending in the 24 months after death, compared to otherwise similar surviv-
ing spouses. In addition, those whose spouses died in the hospital were signifi-
cantly more likely to have an ED visit and a hospital admission after their
spouse’s death. Among those individuals in the highest baseline spending
quartile, in-hospital death was significantly associated with an even greater dif-
ference: $15,000 higher spending 12 months postdeath.
To our knowledge, this study is one of the first to demonstrate that the
experience of the death of one’s spouse may have an important impact on
Table 4: Association between In-Hospital Death and Medicare Expendi-
tures and Utilization for Bereaved Spouses Postdeath by High Baseline Spen-
ders Only
Postdeath Follow-Up Period
12 months Postdeath 24 months Postdeath
N 256 228
Medicare expenditures

















Note. Medicare expenditures are wage index and inflation adjusted to 2012$. Sample propensity
score matched based on: spouse age at death, gender, networth, race, education, self-reported
heath, comorbidity level, caregiving status; decedent age, self-reported health, ADL dependence,
dementia status, cancer diagnosis, level of comorbidity, residence, insurance status; presence of
advance directive; family expectation of death; and EOL spending by hospital referral region and
adjusted for year of death. p-values based onGLM and logistic regression models.
ED, Emergency Department; IQR, interquartile range.
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subsequent health care utilization and spending. Our work adds to a growing
body of literature which finds that high-intensity treatment including hospital-
izations at the EOL may have negative consequences for some patients and
their families (Teno et al. 2004; Christakis and Allison 2006; Wright et al.
2010, 2016; Ornstein et al. 2017a). This is of critical importance given that
despite surveys indicating a preference among those with serious illness to
avoid an in-hospital death and its associated use of high-intensity life-sustain-
ing treatments, in-hospital death remains common (Barnato et al. 2009;
Gomes et al. 2012). The proportion of deaths in acute care hospitals in the
United States was 24.6 percent in 2009 (Teno et al. 2013), and the estimates
are higher for cancer-related deaths (Bekelman et al. 2016).
Furthermore, these analyses suggest that assessment of EOL costs may
need to account for the downstream costs of health care for spouses. Despite a
growing literature demonstrating the evidence to support inclusion of family
“health spillovers” in economic evaluation (Bobinac et al. 2011; Brouwer
et al. 2013; Al-Janabi and Van Exel 2016; Al-Janabi et al. 2016; Fletcher and
Marksteiner 2017), current health care cost estimates do not routinely consider
potential downstream costs associated with the health care expenditures of
family members who care for their seriously ill loved ones (Hurd et al. 2013).
A more comprehensive (and less individualistic) perspective on health care
and assessment of costs is justified as many caregivers are themselves older, in
poor health, and also Medicare beneficiaries (National Academies of Sciences
2016). Future research should examine if the same patterns are found among
couples insured by private health plans.
By linking the health care experiences of individuals to their spouses,
our work highlights the importance of meeting the needs of family caregivers.
Adequate caregiver support throughout the course of serious illness and dur-
ing the EOL period is essential for high-quality patient care and for caregiver
well-being, but it may also have important implications for spending patterns
for surviving spouses. While access to hospice is a core strategy to improve
support for family caregivers at the end of life, supportive services available
for caregivers through hospice may arrive too late to benefit caregivers who
have already experienced substantial caring-related difficulties. Early pallia-
tive care services including caregiving support should be available at any stage
of disease severity that requires caregiving support, and the impact of these
services on families’ health and health care outcomes must be evaluated. More
generally, our findings highlight the importance of recognizing the impact of
serious illness on families, and working to ensure families are fully considered
in efforts to improve the quality and experience of care. Some examples of
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efforts to support families include improving reimbursement mechanisms for
advance care planning discussions, expanding family medical leave and other
legislation to support working family caregivers, and greater research into
interventions designed to support EOL caregivers.
Our findings should be interpreted with a number of potential limita-
tions in mind. Although the mortality follow-back sampling method has
been critiqued (Bach, Schrag, and Begg 2004), this approach is appropriate
for our research question that pertains specifically to the experience of
decedents and the associated outcomes for surviving spouses. Because we
used Medicare claims data to measure costs, we were limited to spouses
with FFS Medicare. On average, individuals incur their highest medical
costs in the last few months of life, so we did not exclude spouses who died
during the 12-month follow-up period, which would bias our findings
toward the null. In sensitivity analyses, we limited our study to 12-month
survivors and also those with uninterrupted FFS Medicare and found no
significant variation in results. Additionally, our use of propensity score
matching, although robust, cannot adjust for unmeasured factors and unob-
served differences between the groups. Importantly, although we exam-
ined a range of patient, spouse, and regional characteristics that may have
accounted for variation in both locations of death and spousal postdeath
spending, we did not have detailed information on individual patient and
family treatment preferences. We were thus unable to determine whether
treatment was concordant with preferences. We also could not assess issues
of prognostic uncertainty, provider communication, options around care
choices, or overall satisfaction with the care received. Although we focus
on all spouses regardless of their caregiving role, because provision of care
is itself endogenous to the health of caregivers, causal effects are difficult to
determine in observational data (Coe and Van Houtven 2009; Do et al.
2015). Finally, our findings regarding changing spending patterns must be
interpreted with caution in light of findings on persistence of health spend-
ing (Hirth et al. 2015). Although our spending-related results were no
longer significant when we included predeath spending quartile in our
match, this could be due to a reduced sample size or to a differential rela-
tionship between location and postdeath spending according to level of
predeath spending. Unfortunately, lack of balance across quartiles pre-
cluded the examination of effects of location of death on spending across
all levels of predeath spending.
While our work demonstrates an association between having an in-hos-
pital death and higher spouse postdeath Medicare expenditures, it raises a
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number of issues that require further study. First, while we focused on site of
death as a marker of treatment intensity, other relevant measures exist,
including number of hospital admissions or days, number of physician visits,
number of transitions in sites of care, and use of life-sustaining interventions
(Luta et al. 2015). Further examination of specific procedures and experi-
ences may shed light on the association described in our study and could
provide an opportunity for improved care quality for both the patient and
spouse. Our study lacked detailed clinical data, so we cannot assess many of
the specific treatments provided or the quality of communication and shared
decision making. Future work could directly assess caregiver experience at
the time of in-hospital death, including possible mediating factors such as
exacerbation of symptoms and high out-of-pocket expenditures. Similarly,
further examination of reasons for spouse hospitalization and ED visits may
help to determine how these may be prevented. For example, are these exac-
erbations of pre-existing illnesses, or are they due to mental health crises that
may be prevented through early increased caregiver support? The vast
majority of spouse hospitalizations captured in this study postdeath (80 per-
cent) were categorized as nonelective. In post hoc analyses, we found that in-
hospital death was similarly associated with a statistically significant increase
in nonelective hospitalizations (data not shown). Moreover, we did not
examine other sources of health care spending, including individual out-of-
pocket expenditures. A better understanding of these costs and household
financial burdens could also reveal opportunities to provide necessary sup-
port services.
CONCLUSIONS
A patient’s family is increasingly recognized as an integral component of the
health care system, and a growing number of informal caregivers provide the
bulk of long-term care in the community at huge unpaid costs (Levine et al.
2010). Meeting the needs of caregivers throughout the course of their loved
one’s serious illness and during the EOL period is a critical component of
high-quality care for patients and promotes caregiver well-being. Our findings
highlight an association between location of death and the surviving spouse’s
subsequent health care utilization, suggesting that there may be an opportu-
nity to better support the needs of caregiving families while lowering down-
stream health care costs.
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